The week to 30 Aug 2024

Newcastle, Saturday 31 AugustPrice movements noted in this article are weekly not dailyI did not publish a Global Influences report last week because of an IT problem. Nothing major to report this week, except …. has NdPr bottomed?Government bondsThe yield of the 30-yr T-Bond (4.20% up 0.09%, wkly, daily) is consolidating within its downtrend.Fiat currenciesThe … Read more

To access this post, you must purchase a membership.

The week to 16 Dec 2022

Newcastle, Saturday 17 DecemberPrice movements noted in this article are weekly not dailyThe chances are that the bear market rally in equity markets is over and that the bear market has resumed.Government bondsThe rally in the T-Bond price ($131.15 up $1.25, wkly, daily) has struggled to gain much more headway. As noted last week, it … Read more

To access this post, you must purchase a membership.

Wed 14 Dec 2022

All Ords 7439 up 50 pts or 0.7%Another quiet day.Portfolio performancesThe Superfund portfolio rose very marginally as follows:A 2.6% rise in Animoca on Primary Markets ($1.95 up 5¢, $1.75/1.95, $3.5b) added 0.4%. A 2.1% fall in Alpha (A4N, 69.5¢ down 1.5¢, $596m, daily, hrly) took 0.3%. A 2.8% fall in Phoslock (PET, 3.4¢ down 0.1¢, … Read more

To access this post, you must purchase a membership.

Weekly market review 2021/1224

Newcastle, Sunday 26 DecemberPrice movements noted in this article are weekly not dailyKept it short this week since nothing much seems to be happeningGovernment bondsThe T-Bond price ($160.46 down $2.09, mthly, wkly, daily) continued in its consolidation pattern. This week I include a link to the monthly chart to show the long term picture, which … Read more

To access this post, you must purchase a membership.

Fri 12 Apr

All Ords 6347 up 53 pts or 0.8%Trading portfolioThis morning I bought into three stocks which had broken out in the last week or two, and as a result the cash position fell from 16% to just 2%. The purchases were:Recce Pharmaceuticals (RCE, 23¢ up 1.5¢, 25m) at an average of 21.6¢.Rhipe (RHP, $2.05 down … Read more

To access this post, you must purchase a membership.

Wed 3 Apr

All Ords 6369 up 41 pts or 0.6%Trading portfolioThe portfolio fell 1.7% due primarily to SDV -9% which fell from 6.6¢ to 6.0¢. I regard the move as just noise in the overall picture. Other poor performers were AMI -5% and ALC -5%. The best performance came from ISX +12% to 32¢ and of course … Read more

To access this post, you must purchase a membership.

Market review 180126

Sunday 28 January Interest rates The tentative break of the long-term trend in US Treasuries remains in place, prices having moved down marginally during the week. Likewise other bond markets. Fiat currencies The USD Index fell more sharply during the week than is normally the case, down 1.5 pts to 89.07 pts. Another half a … Read more

To access this post, you must purchase a membership.

Sale of VPC and half the MMJ

Thursday 13 April This morning I sold out of Velpic (VPC, 1.9¢, $10m) at 1.9¢ and half the MMJ Phytotech (MMJ, 63¢, $129m) at 64.5¢, making sizeable losses on both. I had bought the MMJ at 71¢ and the VPC at 2.7¢, within the last week or two.

To access this post, you must purchase a membership.

Sale of SFI, repurchase of CPH

Monday 10 April This morning I sold out of mapping company Spookfish (SFI, 8.1¢, $68m) at 8.0¢ on a failure of support. I had purchased them at 9.8¢ in February so it was a losing trade. I also bought back into cannabis biotech Creso Pharma (CPH, 76¢, $38m) at 75¢. I had sold out of … Read more

To access this post, you must purchase a membership.

Sale of MMJ

Tuesday 4 April This morning I sold out of medical cannabis stock MMJ Phytotech (MMJ, 70¢, $11m) at an average of 72.8¢ (I sold it in two lots). The stock closed down 5% and in doing so cut support. I hated doing it because I had fallen in love with the stock, but I steeled … Read more

To access this post, you must purchase a membership.

Purchase of TLG

Monday 3 April It would have come to no surprise to readers of last week’s Market Review that this morning I purchased some shares at 51.5¢ in Talga Resources (TLG, 55¢, $100m) after its breakout on Friday. This is about graphene, of course, not boring old graphite. It joins First Graphite (FGR) as the second graphene … Read more

To access this post, you must purchase a membership.

Portfolio review 170331

Saturday 1 April During the week I sold my two remaining iron ore stocks (BCI and MGX) and purchased four new stocks (CPH, LBT, MDC and VPC) including two more medical cannabis stocks making five in total. The cash position is at 5% of the portfolio excluding some cash earmarked for entitlement issues in ARU and … Read more

To access this post, you must purchase a membership.

Purchase of LBT and MDC

Wednesday 29 March Today I bought into yet another pot stock, this one being Medlab Clinical Ltd (MDC, 93¢, $91m) at 95¢, after a breakout yesterday. It is the fifth one I hold. You might well ask, what have I been smoking? I also bought into health care company LBT Innovations Ltd (LBT, 33¢, $46m) … Read more

To access this post, you must purchase a membership.

Portfolio review 170324

Friday 24 March The portfolio fared well this week, up 2% to a YTD return of 8%. Good gains were made by all three pot stocks (AC8, MMJ and ZLD) as well as EHL. But a couple of the bigger holdings, being BCI and TAS, fell moderately and that held back overall performance. At one … Read more

To access this post, you must purchase a membership.

Purchase of AC8 and EOS

Friday 24 March Yesterday I bought into yet another pot stock, being Auscann Group Holdings Ltd (AC8) at 69¢. I also bought back some shares in Electro Optic Systems Ltd (EOS) at $2.58. I had sold out at $2.05 a week or two ago when the stock took a lurch downwards. But it recovered very … Read more

To access this post, you must purchase a membership.

Portfolio review 170317

Sunday 19 March No transactions occurred last week, except that I applied for the MMI shareholder purchase plan entitlement. The portfolio YTD return did not change – it is still 6%. There was a good rise in ZLD but this was offset by small falls in the three biggest holdings, being FBR, FGR and TAS. The … Read more

To access this post, you must purchase a membership.

Portfolio review 170310

Saturday 11 March The portfolio return declined almost 1% last week, to 6% YTD. Good performances were seen in MMJ and FBR, but the iron ore plays continued their decline. The portfolio consists of 21 stocks, most accounting for less than 5% of the portfolio. Biggest equity holdings are now FBR and TAS, each accounting … Read more

To access this post, you must purchase a membership.

Purchase of ZLD and more FBR

Saturday 11 March Yesterday I bought into Zelda Therapeutics Ltd (ZLD, 6.0¢, $19m, another marijuana hopeful) at 6.8¢ upon a breakout from a large triangular bottom formation. The stock retreated later in the day but to me, the chart still looks good. I also doubled up on my holding of Fastbrick Robotics (FBR, 10¢, $64m) … Read more

To access this post, you must purchase a membership.

Sale of BRN, EOS, GGR and PAC

Tuesday 28 February The portfolio was shot to pieces today and I am not happy. Managed to sell some stock. It’s interesting that even the iron ore stocks are weak when the commodity is strong. But that’s the market for you. — BRN was sold at 25¢ for a small gain. They closed today unchanged … Read more

To access this post, you must purchase a membership.

Portfolio review 170224

Friday 24 February It was a disastrous week, with the returns down 6% for the week and the YTD returns now standing at 11%. And I was feeling so smug in the last few weeks. In particular, EDE/TAS could not maintain their upward momentum in view of the implication from the quarterly that growth in … Read more

To access this post, you must purchase a membership.

Sale of MLM, purchase of MMJ

Thursday 23 February Today I took advantage of today’s surge in price to sell out of MLM at 8.2¢. The stock had also come close to resistance derived from a line drawn across tops in August 2014 and November 2015. I had bought the stock at 4.9¢ in November 2016, sold half at 6.9¢ in January … Read more

To access this post, you must purchase a membership.

Purchase of CZI, partial sale of BRN and MGX, full sale of AGO, ANG, ARU and LER

Wednesday 22 February A very active day today, buying one stock and selling six, the latter partly because I had run out of cash and needed some flexibility, and partly because some of their charts were looking a bit flaky or in the case of MGX, had run very hard. Cassini (CZI) was purchased at … Read more

To access this post, you must purchase a membership.

Portfolio review 170217

Friday 17 February It was a good week for the trading portfolio with returns up 5% for the week, thus boosting the YTD return to 17%. Phenomenal performances were achieved by LYC up 47% and MGX up 37%, while good performances of 10-20% were made by BCI, ARU, GRR and MUS. Basically it was a great … Read more

To access this post, you must purchase a membership.